SCHEMBL6126567

SCHEMBL6126567

CNc1nccc(-c2cc(NC3CCN(C)CC3)c3cc(OC)ccc3c2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 3/20 0.48
EZH2 Q15910 2/20 0.48
EIF2AK2 P19525 1/20 0.44
MAPK14 Q16539 1/20 0.44
EHMT1 Q9H9B1 1/20 0.42
RET P07949 1/20 0.41
MKNK1 Q9BUB5 2/20 0.41
IGF1R P08069 1/20 0.41
TTK P33981 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
CDK4 P11802 2/20 0.39
CCND1 P24385 2/20 0.39
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
CCNA2 P20248 1/20 0.39
CDK2 P24941 1/20 0.39
CCNA1 P78396 1/20 0.39
EHMT2 Q96KQ7 2/20 0.39
MAPK8 P45983 2/20 0.39
DNMT1 P26358 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179297 0.89 EIF2AK2 (0.41) EZH2EIF2AK2EHMT1MKNK1
SCHEMBL2176320 0.88 NOS3 (0.41) IKBKBEZH2EIF2AK2MKNK1CDK2
SCHEMBL2175893 0.88 MKNK1 (0.51) IKBKBEIF2AK2MAPK14MKNK1CDK4
SCHEMBL6125386 0.87 IKBKB (0.51) IKBKBMAPK14RETCDK4CCND1
SCHEMBL2179393 0.87 EHMT1 (0.40) IKBKBEZH2EIF2AK2EHMT1MKNK1
SCHEMBL2179213 0.86 EIF2AK2 (0.39) IKBKBEZH2EIF2AK2EHMT1MKNK1
SCHEMBL12489868 0.86 EIF2AK2 (0.39) IKBKBEZH2EIF2AK2MKNK1
SCHEMBL12489870 0.86 EZH2 (0.41) EZH2EIF2AK2MKNK1KCNH2MAPK10
SCHEMBL12489865 0.85 EZH2 (0.41) EZH2EIF2AK2MKNK1
SCHEMBL12486630 0.85 CCNC (0.38) IKBKBEZH2EIF2AK2RETMKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP IKBKB 401/4885EZH2 1761/4885EIF2AK2 1269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.